![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network ... Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions. Show more
BALTIMORE, Md. and BASKING RIDGE, N.J., July 18, 2024 (GLOBE NEWSWIRE) -- Haystack Oncology, a Quest Diagnostics (NYSE: DGX) company, and Lisata Therapeutics, Inc. (Nasdaq: LSTA), a...
Quest Diagnostics to Acquire Outreach Laboratory Services of OhioHealth PR Newswire SECAUCUS, N.J. and COLUMBUS, Ohio, July 10, 2024 Goal to broaden access to cost-effective and innovative...
Quest Diagnostics to Acquire LifeLabs from OMERS, Enhancing Diagnostic Services for Canadians PR Newswire SECAUCUS, N.J. and TORONTO, July 3, 2024 SECAUCUS, N.J. and TORONTO, July 3, 2024...
Quest Diagnostics Releases 2023 Corporate Responsibility Report PR Newswire SECAUCUS, N.J., June 27, 2024 SECAUCUS, N.J., June 27, 2024 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in...
Quest Diagnostics to Acquire Select Lab Assets from Allina Health PR Newswire SECAUCUS, N.J. and MINNEAPOLIS, June 26, 2024 Transaction to broaden access to Quest's innovative and cost-effective...
Quest Diagnostics to Release Second Quarter 2024 Financial Results on July 23, 2024 PR Newswire SECAUCUS, N.J., June 19, 2024 SECAUCUS, N.J., June 19, 2024 /PRNewswire/ -- Quest Diagnostics...
Quest Diagnostics Completes Acquisition of Select PathAI Diagnostics' Lab Assets from PathAI, Accelerating Adoption of AI and Digital Pathology to Speed Cancer Diagnosis PR Newswire SECAUCUS...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.92 | 1.33250052051 | 144.09 | 150.585 | 143.74 | 945414 | 146.71596987 | CS |
4 | 6.65 | 4.77181400689 | 139.36 | 150.585 | 136.3 | 844482 | 141.73306206 | CS |
12 | 11.51 | 8.55762081784 | 134.5 | 150.585 | 134.26 | 862489 | 140.50898454 | CS |
26 | 13.3 | 10.0218521588 | 132.71 | 150.585 | 123.04 | 975263 | 133.47408353 | CS |
52 | 1.64 | 1.13597007689 | 144.37 | 150.585 | 119.59 | 928764 | 132.77165718 | CS |
156 | 9.62 | 7.05330302808 | 136.39 | 174.16 | 119.59 | 1042495 | 139.19815937 | CS |
260 | 46.33 | 46.4787319422 | 99.68 | 174.16 | 73.01 | 1136458 | 127.53363198 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions